{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:09:29Z","timestamp":1784128169304,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Acute generalized exanthematous pustulosis (AGEP) is a rare but severe skin eruption rarely induced by iodinated contrast media (ICMs). We report a clinical observation of AGEP induced by iodixanol with cross-reactivity with other ICMs, confirmed by positive intradermal tests (IDTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A 72-year-old female patient with no history of atopy, skin disease, or adverse drug reaction or allergy to iodine was diagnosed with acute coronary syndrome and underwent a rescue angioplasty using iodixanol as ICM. Four days later, the patient developed a morbilliform maculopapular rash with small nonfollicular pustules overspreading the entire body, accompanied by fever of 39.5 \u00b0C and vomiting. Laboratory investigations showed marked leukocytosis with neutrophilia and eosinophilia, and a high creatinine level. Clopidogrel was initially considered as the causative drug, and the patient was switched to ticagrelor, with a partial regression of the skin manifestations. However, 11 days after the angiography, the patient underwent a computed tomography scan using iodixanol, leading to a reactivation of the exanthema, accentuation of pustules, a high body temperature of 38.5 \u00b0C, and the reappearance of leukocytosis, neutrophilia, and eosinophilia. The diagnosis of AGEP was confirmed by a EuroSCAR score of 9, and iodixanol was highly suspected to be the culprit agent. Six weeks after the patient\u2019s complete recovery, an intradermal test with iodixanol was conducted according to the European Network of Drug Allergy (ENDA) recommendations, with the patient\u2019s informed consent, yielding a positive result at the 48-hour reading. To assess for cross-reactivity with other ICMs, IDTs with iopromide, iohexol, and iopamidol, were performed. All IDTs were positive at the 48-hour reading.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We report a rare case of AGEP induced by iodixanol and point out the potential cross-reactivity between iodixanol, iopamidol, iopromide, and iohexol. IDTs for a wide range of ICMs should be conducted to identify safe alternatives for patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag196","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:17:26Z","timestamp":1782904646000},"source":"Crossref","is-referenced-by-count":0,"title":["Iodixanol-induced acute generalized exanthematous pustulosis: Cross-reactivity to other iodinated contrast media"],"prefix":"10.1093","author":[{"given":"Hela","family":"Trimech","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Fattouma Bourguiba University Hospital , Monastir , , Monastir ,","place":["Tunisia"]},{"name":"and University of Monastir , Monastir , , Monastir ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Ben Romdhane","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Fattouma Bourguiba University Hospital , Monastir , Monastir ,","place":["Tunisia"]},{"name":", and University of Monastir , Monastir , Monastir ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marouane","family":"Mahjoub","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fattouma Bourguiba University Hospital, Monastir, and University of Monastir , Monastir ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Chadli","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Fattouma Bourguiba University Hospital , Monastir , , Monastir ,","place":["Tunisia"]},{"name":"and University of Monastir , Monastir , , Monastir ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ben Fredj","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Fattouma Bourguiba University Hospital , Monastir , , Monastir ,","place":["Tunisia"]},{"name":"and University of Monastir , Monastir , , Monastir ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Aouam","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Fattouma Bourguiba University Hospital , Monastir , , Monastir ,","place":["Tunisia"]},{"name":"and University of Monastir , Monastir , , Monastir ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"4","key":"2026071510414090400_zxag196-B1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1472-8206.2009.00794.x","article-title":"Acute generalized exanthematous pustulosis (AGEP) induced by cefotaxime","volume":"24","author":"Chaabane","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"2026071510414090400_zxag196-B2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s40257-023-00779-3","article-title":"Acute generalized exanthematous pustulosis: clinical features, differential diagnosis, and management","volume":"24","author":"Parisi","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"2026071510414090400_zxag196-B3","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.jaip.2021.02.060","article-title":"DRESS and AGEP reactions to iodinated contrast media: a French case series","volume":"9","author":"Soria","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"suppl 1","key":"2026071510414090400_zxag196-B4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2500\/aap.2012.33.3561","article-title":"Chapter 28: classification of hypersensitivity reactions","volume":"33","author":"Uzzaman","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"2026071510414090400_zxag196-B5","volume-title":"StatPearls","author":"Moore","year":"2024"},{"issue":"2","key":"2026071510414090400_zxag196-B6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/jcm11020397","article-title":"Drug triggers and clinic of acute generalized exanthematous pustulosis (AGEP): a literature case series of 297 patients","volume":"11","author":"Vallejo-Yag\u00fce","year":"2022","journal-title":"J Clin Med"},{"issue":"6-7","key":"2026071510414090400_zxag196-B7","first-page":"612","article-title":"Centres R\u00e9gionaux de Pharmacovigilance. Drugs associated with acute generalized exanthematic pustulosis. Article in French","volume":"130","author":"Saissi","year":"2003","journal-title":"Ann Dermatol Venereol"},{"issue":"9","key":"2026071510414090400_zxag196-B8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","article-title":"Acute generalized exanthematous pustulosis: analysis of 63 cases","volume":"127","author":"Roujeau","year":"1991","journal-title":"Arch Dermatol"},{"issue":"6","key":"2026071510414090400_zxag196-B9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jaip.2014.07.015","article-title":"Iodinated contrast media-induced acute generalized exanthematous pustulosis confirmed by delayed skin tests","volume":"2","author":"Grandvuillemin","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"2026071510414090400_zxag196-B10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/cod.12724","article-title":"Acute generalized exanthematous pustulosis caused by an iodinated contrast radiocontrast medium for computed tomography arthrography of the knee","volume":"76","author":"Velter","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"2","key":"2026071510414090400_zxag196-B11","doi-asserted-by":"publisher","first-page":"W198","DOI":"10.2214\/AJR.05.0317","article-title":"Acute generalized exanthematous pustulosis as a delayed dermatotoxic reaction to IV-administered nonionic contrast media","volume":"187","author":"Peterson","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"2026071510414090400_zxag196-B12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4168\/aard.2018.6.5.270","article-title":"Radiocontrast media-induced acute generalized exanthematous pustulosis: a safe administration of alternative radiocontrast media using patch tests","volume":"6","author":"Kim","year":"2018","journal-title":"Allergy Asthma Respir Dis"},{"issue":"5","key":"2026071510414090400_zxag196-B13","doi-asserted-by":"publisher","first-page":"e41301","DOI":"10.1097\/MD.0000000000041301","article-title":"Rare acute generalized exanthematous pustulosis caused by iodixanol: a case report","volume":"104","author":"Ma","year":"2025","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"2026071510414090400_zxag196-B14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/jcdd10110449","article-title":"Efficacy and safety of iodixanol in computed coronary tomographic angiography and cardiac catheterization","volume":"10","author":"Budoff","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"4","key":"2026071510414090400_zxag196-B15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/s1085-5629(96)80037-x","article-title":"Acute generalized exanthematous pustulosis","volume":"15","author":"Beylot","year":"1996","journal-title":"Semin Cutan Med Surg"},{"issue":"3","key":"2026071510414090400_zxag196-B16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.reval.2022.02.139","article-title":"Pustulose exanth\u00e9matique aigu\u00eb g\u00e9n\u00e9ralis\u00e9e (PEAG) : exp\u00e9rience de 17 ans","volume":"62","author":"Chaabane","year":"2022","journal-title":"Rev Fr Allergol"},{"issue":"3","key":"2026071510414090400_zxag196-B17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP) a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"issue":"4","key":"2026071510414090400_zxag196-B18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/15569527.2014.961071","article-title":"Acute generalized exanthematous pustulosis induced by iodixanol (Visipaque): a serious reaction to a commonly used drug","volume":"34","author":"Ozturk","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"2026071510414090400_zxag196-B19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2026071510414090400_zxag196-B20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2133.1971.tb07198.x","article-title":"Pustular eruption with eosinophilic abscesses","volume":"85","author":"Stevanovic","year":"1971","journal-title":"Br J Dermatol"},{"issue":"suppl 4","key":"2026071510414090400_zxag196-B21","first-page":"6","article-title":"Toxic pustuloderma a new entity?","volume":"77","author":"Staughton","year":"1984","journal-title":"J R Soc Med"},{"issue":"9","key":"2026071510414090400_zxag196-B22","first-page":"467","article-title":"Medikamenten allergishe vasculitis leucocytoclastica unter dem bil deines generalisierten pustulosen exanthems. [Leukocytoclastic vasculitis due to drug allergy presenting as generalized pustular exanthema]. Article in German","volume":"32","author":"Rockl","year":"1981","journal-title":"Hautarzt"},{"issue":"5","key":"2026071510414090400_zxag196-B23","first-page":"407","article-title":"Acute generalized exanthematic pustulosis. Imputability of imipenem (Tienam)","volume":"116","author":"Escallier","year":"1989","journal-title":"Article in French. Ann Dermatol Venereol"},{"issue":"6","key":"2026071510414090400_zxag196-B24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/all.12589","article-title":"Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis","volume":"70","author":"Yoon","year":"2015","journal-title":"Allergy"},{"issue":"2","key":"2026071510414090400_zxag196-B25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaci.2015.07.035","article-title":"Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions","volume":"137","author":"Lerondeau","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2026071510414090400_zxag196-B26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1398-9995.2008.01832.x","article-title":"European Network of Drug Allergy and the EAACI Interest Group on Drug Hypersensitivity. Skin testing in patients with hypersensitivity reactions to iodinated contrast media: a European multicenter study","volume":"64","author":"Brockow","year":"2009","journal-title":"Allergy"},{"issue":"7","key":"2026071510414090400_zxag196-B27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1398-9995.2012.02840.x","article-title":"Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media","volume":"67","author":"Torres","year":"2012","journal-title":"Allergy"},{"issue":"6","key":"2026071510414090400_zxag196-B28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.0105-1873.2004.00367.x","article-title":"Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media","volume":"50","author":"Vernassiere","year":"2004","journal-title":"Contact Dermatitis"},{"issue":"1","key":"2026071510414090400_zxag196-B29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cod.13242","article-title":"Acute generalized exanthematous pustulosis induced by iomeprol with cross-reactivity to other iodinated contrast agents and mild reactions after rechallenge with iopromide and oral corticosteroid premedication","volume":"81","author":"Machet","year":"2019","journal-title":"Contact Dermatitis"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag196\/68663928\/zxag196.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag196\/68663928\/zxag196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:41:49Z","timestamp":1784126509000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article\/doi\/10.1093\/ajhp\/zxag196\/8722811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag196","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"zxag196"}}